INIS
breasts
100%
cancer
100%
chemotherapy
12%
cost
15%
diseases
16%
growth factors
26%
hazards
12%
hormones
34%
hospitals
18%
humans
26%
implementation
11%
metastases
17%
netherlands
55%
patients
82%
receptors
44%
teaching
5%
therapy
39%
trajectories
7%
Keyphrases
Advanced Breast Cancer
84%
Breast Cancer Patients
8%
Cancer Registry
42%
Chemotherapy
14%
Confidence Interval
10%
Everolimus
8%
Exemestane
7%
HER2+
34%
HER2-positive Advanced Breast Cancer
15%
HER2-targeted Therapy
13%
Hormone Receptor
34%
Hormone Receptor-positive
12%
Hospital Type
7%
Human Epidermal Growth Factor Receptor
8%
Human Epidermal Growth Factor Receptor 2 (HER2)
33%
Initial Treatment
7%
Life Studies
9%
Metastatic Breast Cancer
8%
Netherlands
55%
Overall Survival
9%
Pertuzumab
17%
Progression-free Survival
18%
Real-world Treatment Patterns
7%
Systemic Therapy
14%
Systemic Treatment
9%
Time Trends
7%
Trastuzumab
9%
Trastuzumab Resistance
7%
Treatment Choice
16%
Treatment Outcome
8%
Medicine and Dentistry
Biopsy Technique
7%
Breast Cancer
51%
Cancer Registry
24%
Chemotherapy
13%
Disease
5%
Epidermal Growth Factor Receptor
8%
Epidermal Growth Factor Receptor 2
9%
Gamma Urogastrone
17%
Health Care
5%
Hormone Receptor
21%
Metastatic Breast Cancer
13%
Overall Survival
13%
Pertuzumab
5%
Progression Free Survival
9%
Systemic Therapy
13%
Targeted Therapy
11%